Home Newsfeeds William Blair Downgrades BRP Group to Market Perform

William Blair Downgrades BRP Group to Market Perform

William Blair analyst Adam Klauber downgrades BRP Group (NASDAQ:BRP) from Outperform to Market Perform.

byBenzinga Newsdesk

March 3, 2023

1 minute read

William Blair analyst Adam Klauber downgrades BRP Group (NASDAQ:BRP) from Outperform to Market Perform.

‘Activision Blizzard Lays Off 50 Employees From Esports Division; Despite Record Sales Numbers Thanks To Diablo 4’ – EuroGamer

By Happy Mohamed

July 20, 11:48 AM

https://www.eurogamer.net/activision-blizzard-lays-off-50-employees-from-esports-division Activision Blizzard has laid off around 50 staff from its esports division. The layoffs come amid news of the

ATVI

FDA
News

Apellis Announces Plans To Submit 24-Month Phase 3 Data To FDA For Pegcetacoplan NDA For Geographic Atrophy

By Benzinga Newsdesk

November 3, 5:20 PM

Inclusion of the 24-month data has the potential to strengthen the product profile at launch, with minimal impact to launch timing Submission will be a Major Amendment to the New Drug Application (NDA), extending

APLS

Wells Fargo Maintains Underweight on Owl Rock Capital, Raises Price Target to $11.5

By Benzinga Newsdesk

November 4, 12:03 PM

Wells Fargo analyst Finian O'Shea maintains Owl Rock Capital (NYSE:ORCC) with a Underweight and raises the price target from $10 to $11.5.

ORCC

News

Parsons Charges Up Zero Emission Vehicle And Fleet Electrification Business

By Benzinga Newsdesk

October 26, 4:49 PM

Parsons Corporation (NYSE:PSN) is leveraging their qualifications as a provider of detailed design and transit planning services to guide transit agencies through new fleet electrification and zero emission vehicle (ZEV)

PSN

William Blair Downgrades BRP Group to Market Perform

Related Posts

‘Activision Blizzard Lays Off 50 Employees From Esports Division; Despite Record Sales Numbers Thanks To Diablo 4’ – EuroGamer

Apellis Announces Plans To Submit 24-Month Phase 3 Data To FDA For Pegcetacoplan NDA For Geographic Atrophy

Wells Fargo Maintains Underweight on Owl Rock Capital, Raises Price Target to $11.5

Parsons Charges Up Zero Emission Vehicle And Fleet Electrification Business